Investigation of Pajanelia longifolia Leaf Extract for Antidiabetic Activity
Sreelakshmi1, Khandige PS1*, Sadananda V2
1NITTE (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Pharmacology, Deralakatte, Mangaluru-575018, Karnataka, India
2NITTE (Deemed to be University), AB Shetty Memorial Institute of Dental Sciences (ABSMIDS), Department of Conservative Dentistry and Endodontics, Deralakatte, Mangaluru-575018, Karnataka, India
Received: 4th Jul, 2024; Revised: 27th Oct, 2024; Accepted: 3rd Nov, 2024; Available Online: 25th Dec, 2024
ABSTRACT
Diabetes mellitus (DM) is a medical condition characterized by heightened levels of blood sugar, stemming from either inadequate production of insulin or an impaired response to insulin at the cellular level, whether due to a relative or absolute deficiency of the hormone. Traditional herbal remedies have a significant role in the treatment of DM. Pajanelia longifolia, known by the general population as Pajanelia or Tender wild jack has been a component of traditional herbal medicine in India and other Asian countries for the treatment of various ailments. The current research assessed the antidiabetic activity of Pajanelia longifolia leaf extract in streptozotocin (35 mg/kg, oral route) induced diabetic rats. The study utilized an in vivo streptozotocin induced diabetic model and an in vitro rat hemidiaphragm model for assessment of antidiabetic activity. Acute toxicity studies conducted on liposomes of Pajanelia longifolia leaf extract (2000 mg/kg body weight) proved the drug to be non-toxic. The effects of various doses (100, 200 and 400 mg/kg p.o.) of extract were assessed. Glimepiride (2 mg/kg) and insulin (0.25 IU/ml) were used as the standard drugs for in vivo and in vitro studies, respectively. The decrease in blood glucose levels and the elevation of muscle and liver glycogen content in diabetic rats induced by streptozotocin and the increased glucose uptake and glycogen content observed in in vitro rat hemidiaphragm technique proved that Pajanelia longifolia leaf extract has significant antidiabetic activity.
Keywords: Pajanelia longifolia, Antidiabetic, Streptozotocin, Glimepiride, Rat hemidiaphragm.
How to cite this article: Sreelakshmi, Khandige PS, Sadananda V. Investigation of Pajanelia longifolia Leaf Extract for Antidiabetic Activity. International Journal of Drug Delivery Technology. 2024;14(4):2029-33. oi:10.25258/ijddt.14.4.12
REFERENCES
- World Health Organization., WHO Study Group of Prevention of Diabetes Mellitus. WHO Tec Ser. 1994;844:11.
- Siddharth NS. Containing the global epidemic of diabetes. J Diabetol. 2001;3:11.
- Nasri H, Shirzad H, Baradaran A, Rafieian-Kopaei M. Antioxidant plants and diabetes J Res Med Sci. 2015;20(5):491.
- Veerapur VP, Prabhakar KR, Thippeswamy BS, Bansal P, Srinivasan KK, Unnikrishnan MK. Antidiabetic effect of Ficus racemosa Linn. stem bark in high- fat diet and low dose streptozotocin-induced type 2 diabetic rats: A mechanistic study. Food Chem [Internet]. 2012 May [cited 2021 May 7];132(1):186–93.
- Holman RR, Turner RC. Oral agents and insulin in the treatment of In: Pickup J, Williams G, editors. Textbook of Diabetes. Oxford: Blackwell; 1991. p. 467- 469.
- Kumar BD, Mitra A, Manjunatha In vitro and in vivo studies of antidiabetic Indian medicinal plants: a review. J Herb Med Toxicol. 2009;3(2):9-14.
- Rahimi R, Nikfar S, Larijani B, Abdollahi A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother. 2005 Aug 1;59(7):365-73.
- Firenzuoli F, Gori L. Herbal Medicine Today: Clinical and Research Issues. Evid Based Complement Altern Med [Internet]. 2007;4:594728.
- Steffy K, Shanthi G, Natarajan V. Chemical Composition and Antibacterial Activity of Pajanelia longifolia (Willd.) K.Schum against Multi-Drug Resistant Clinical Isolates from Diabetic Foot Int J Adv Res. 2017;5(4):907-915.
- Saha P, Talukdar AD, Choudhury MD. Antioxidant Potential Profile of Pajanelia longifolia (Willd.) K. Schuman; Potential New Sources of Natural Antioxidant. Asian J Pharm Clin Res. 2017;10(6):184-
- Kokate CK, Purohit PA, Gokhale BS. 22nd ed. Pune: Nirali Prakashan; 2003. p.207-232.
- Trease EG, Evans CW. Pharmacognosy. 12th ed. Eastbourne: English language Book society; 1985. p.539, 344.
- New OECD 425 guidelines. OECD Guidelines for testing animals. 2001;26:1-26.
- Ghosh MN. Fundamentals of Experimental Pharmacology. 3rd ed. Kolkata: Hilton and company.
- Turner RA. Screening methods in pharmacology. New York: Academic Press INC;1965.
- Gupta SK. Drug screening method-preclinical evaluation of new drugs. 2nd edition. Jaypee medical publishers. 2009. p.591-592.
- Vogel HG. Drug discovery and evaluation Pharmacological assay. New York: Springer Verlag Berlin Heidelberg. 2002. p.947-1051.
- Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol. 1969 Mar 1;22(2):158-61.